JakartaGlobe-Dec 27

Kalbe Farma, Indonesia’s largest listed pharmaceutical company by market capitalization, is hopeful that a Covid-19 vaccine the company help develop with South Korea’s Genexine would be ready for emergency use by September next year, potentially adding a lucrative business to the company’s line amid its aggressive expansions. The vaccine has cleared the first clinical trial phase. Kalbe Farma helped prepare the second clinical trial, which typically involves more subjects than the first, to assess the vaccine’s proper dosage. Genexine plans to run the trial in Indonesia and South Korea. Kalbe Farma is among local pharmaceutical companies that help develop the Covid-19 vaccine in Indonesia.

Read more at: https://jakartaglobe.id/business/kalbe-is-hopeful-genexines-covid19-vaccine-ready-by-q3-2021